Molecule Details
| InChIKey | VCRJPKGMKUCDMV-BAQBVXSRSA-N |
|---|---|
| Compound Name | 4-[4-[[(2R,3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-yl]oxymethyl]triazol-1-yl]benzenesulfonamide |
| Canonical SMILES | NS(=O)(=O)c1ccc(-n2cc(CO[C@@H]3O[C@H](COCc4ccccc4)[C@@H](OCc4ccccc4)[C@H]3OCc3ccccc3)nn2)cc1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.77 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile